(Total Views: 65)
Posted On: 08/12/2024 10:34:54 PM
Post# of 69
MindMed - Corporate Presentation - August 2024
https://d1io3yog0oux5.cloudfront.net/_1563511...t+2024.pdf
It seems like perhaps the recent offering was to help fund a P3 on MM-120 for MDD. If I remember correctly there were some people in the P2b GAD trial with MDD. They had such a good reaction to MM-120 that MindMed is now allowed to skip right to p2b. I don't recall seeing anything about skipping all the way to a P3 for MDD but that looks possible and crazy if so.
https://d1io3yog0oux5.cloudfront.net/_1563511...t+2024.pdf
It seems like perhaps the recent offering was to help fund a P3 on MM-120 for MDD. If I remember correctly there were some people in the P2b GAD trial with MDD. They had such a good reaction to MM-120 that MindMed is now allowed to skip right to p2b. I don't recall seeing anything about skipping all the way to a P3 for MDD but that looks possible and crazy if so.
(0)
(0)Scroll down for more posts ▼
